HK1005565A1 - Pharmaceutical compositions active on the cardiovascular system containing 3- mehtylthiopropionyl l- carnitine - Google Patents

Pharmaceutical compositions active on the cardiovascular system containing 3- mehtylthiopropionyl l- carnitine

Info

Publication number
HK1005565A1
HK1005565A1 HK98104739A HK98104739A HK1005565A1 HK 1005565 A1 HK1005565 A1 HK 1005565A1 HK 98104739 A HK98104739 A HK 98104739A HK 98104739 A HK98104739 A HK 98104739A HK 1005565 A1 HK1005565 A1 HK 1005565A1
Authority
HK
Hong Kong
Prior art keywords
carnitine
cardiovascular system
mehtylthiopropionyl
pharmaceutical compositions
system containing
Prior art date
Application number
HK98104739A
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1005565A1 publication Critical patent/HK1005565A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

3-methylthiopropionyl L-carnitine and its pharmacologically acceptable salts are active on the cardiovascular system, particularly in the treatment of myocardial anoxia, cardiac ischaemia, arrhythmias and congestive heart failure.
HK98104739A 1990-03-15 1998-06-02 Pharmaceutical compositions active on the cardiovascular system containing 3- mehtylthiopropionyl l- carnitine HK1005565A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47759A IT1240799B (en) 1990-03-15 1990-03-15 PHARMACEUTICAL COMPOSITIONS CONTAINING 3-METHYLTHIOPROPIONYL L-CARNITINE FOR ACTIVITY ON THE CARDIOVASCULAR SYSTEM.

Publications (1)

Publication Number Publication Date
HK1005565A1 true HK1005565A1 (en) 1999-01-15

Family

ID=11262331

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104739A HK1005565A1 (en) 1990-03-15 1998-06-02 Pharmaceutical compositions active on the cardiovascular system containing 3- mehtylthiopropionyl l- carnitine

Country Status (9)

Country Link
US (1) US5173508A (en)
EP (1) EP0448523B1 (en)
JP (1) JPH04217656A (en)
AT (1) ATE122561T1 (en)
DE (1) DE69109721T2 (en)
DK (1) DK0448523T3 (en)
ES (1) ES2072591T3 (en)
HK (1) HK1005565A1 (en)
IT (1) IT1240799B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (en) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ACYL-CARNITINE ASSOCIATION WITH ACE-INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
IT1263004B (en) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti USE OF L-CARNITINE AND ACIL L-CARNITINE IN THE LONG-TERM TREATMENT OF NON-INSULIN-EMPLOYEE DIABETIC PATIENTS.
IT1276225B1 (en) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ALKANOYL L-CARNITINE IN ASSOCIATION WITH RESVERATROL OR ITS DERIVATIVES USEFUL FOR
IT1276253B1 (en) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR ALCANOIL L-CARNITINE FOR THE PREVENTION AND TREATMENT OF SOFT STATES
IT1291113B1 (en) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
PT951909E (en) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti A COMPOSITION WHICH CONTAINS A L-CARNITINE OR ALCANOYL-L-CARNITINE A GLYCOSAMINOGLYCANO AND / OR ITS CONSTITUENT

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1116037B (en) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS AND AMIDS THEIR PREPARATION PROCEDURES AND THERAPEUTIC USE
IT1145371B (en) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti ALCOSSI-ACIL CARNITINE PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1170862B (en) * 1981-03-31 1987-06-03 Sigma Tau Ind Farmaceuti MERCAPTOACIL-CARNITINE PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE
IT1177874B (en) * 1984-07-04 1987-08-26 Sigma Tau Ind Farmaceuti ESTERS OF ACETYL CARNITINE, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Also Published As

Publication number Publication date
IT1240799B (en) 1993-12-17
IT9047759A1 (en) 1991-09-15
US5173508A (en) 1992-12-22
ES2072591T3 (en) 1995-07-16
DE69109721T2 (en) 1995-10-26
ATE122561T1 (en) 1995-06-15
DE69109721D1 (en) 1995-06-22
IT9047759A0 (en) 1990-03-15
JPH04217656A (en) 1992-08-07
EP0448523B1 (en) 1995-05-17
EP0448523A2 (en) 1991-09-25
DK0448523T3 (en) 1995-06-06
EP0448523A3 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
AU2235092A (en) Bipolar cardiac lead
ZA925698B (en) Treatment of congestive heart failure.
AU1497692A (en) Sulfonamides and their medical use
EP0458641A3 (en) Use of prostaglandin derivatives in the treatment of congestive heart failure
CA2194218A1 (en) Hydrosoluble organic salts of creatine
TR200201059T2 (en) Novel oxabispidine compounds useful in the treatment of cardiac arrhythmias
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
EP0424525A4 (en) Novel amines and their use.
EP0448523A3 (en) Pharmaceutical compositions active on the cardiovascular system, containing 3-methylthiopropionyl l-carnitine
CA2292226A1 (en) Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use
IL90551A0 (en) Stable,injectable,aqueous pharmaceutical compositions for the treatment of cardiac conditions
CA2135614A1 (en) Use of urodilatin in pulmonary and bronchial diseases
HK1009139A1 (en) New 6-hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
OA09843A (en) 2-Amino-1, 2, 3, 4-tetahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
CA2114859A1 (en) Cytotoxic and antiviral compound
IT1275935B1 (en) AMINOTETRALINE DERIVATIVES FOR THERAPY OF CARDIOVASCULAR DISEASES
EP0495106A4 (en) Osteogenesis promoter
NO891046D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,2,4-TRIAZOL DERIVATIVES.
AU2001296173A1 (en) 3,8-diazabicyclo(3.2.1)octanes and their use in the treatment of cardiac arrhythmias
GR3025064T3 (en) New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardio-vascular system, processes for their preparation and pharmaceutical compositions containing same
NO165542C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ARYL-2,4-DIALKYL-3H-1,2,4-TRIAZOL-3-THIONER.
ZA937085B (en) e derivatives active on the cardiovascular system 17-Aryl and 17-heterocyclyl-5Beta-14Beta androstanprocesses for their preparation and pharmaceutical compositions containing same
GR3029466T3 (en) 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
GR3031908T3 (en) Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060311